This week marked the release of new draft FDA guidance on cell and gene therapies. Is the FDA kind of like the guidance counselor at school or more like the principal? It probably depends on many factors. I also find it funny how pretty much everyone in academia and biotech industry works to be compliant […]
Weekly reads: New FDA guidance, brains, MSCs, senescence Read More »
Stem cell clinic firms often come and go rather quickly, but a few like Regenexx have persisted. It’s even become a brand name. I’ve been writing here on The Niche for more than twelve years about stem cell clinics. Regenexx has been around that whole time. Along with its founder Dr. Chris Centeno. Patients have
Fact-checking Regenexx: reviews, data & cost Read More »
A piece on human tails and how we lost them caught my eye so I’ll start my weekly reads with that. This week I had the fewest Zoom meetings in ages, which allowed me to get more work done in my own lab and more reading. How about that? I even had some in-person meetings
Recommended reads: a tale of human tails, heart reprogramming, pericytes, microglia Read More »
The push for de-extinction of woolly mammoths is a perfect example of when one notion can be both fun and a rotten idea. You can’t let the coolness push you down a bad path. You can see my new YouTube video covering the main points of this post from our YouTube channel further down. Please
Why De-extinction of Woolly Mammoths is Still a Bad Idea Read More »
I’ve been following the research related to human cloning now for more than a decade. Is human cloning more possible at this point? How do we even define such cloning? Did you know there are two types? The goal of this post is to educate you and in the process answer such questions. What’s in
Human cloning is more likely now but would you take the big risks? Read More »
I love stem cell research but experiments that have practical possible future applications in medicine like for vision loss are especially interesting to me. On the other hand basic research on core transcription factor mechanisms like by MyoD also really grab me. We cover some of this stuff and other ground in today’s recommended reads.
Weekly reads: vision, MyoD, liver regen, more Read More »
I’m taking a short break today from working on a big grant to put out this weekly reads post including on Sox transcription factors, cord blood paper controversy, and other interesting papers such as one on CTCF and chromatin domains after mitosis that really struck me. I can actually see blue sky today here in
Weekly reads: CTCF, Sox transcription factors, Clinic fires back, more Read More »
It’s been a little quiet here on The Niche for the past week as I was off in Yellowstone National Park, but I’m back with this week’s recommended weekly reads including a section on organoids. First, I want to share a nature pic from the trip. A highlight was encountering a badger in Lamar Valley
Weekly reads: badgers, organoids, The Onion, & more Read More »
One of my favorite types of papers are those on stem cells and chromatin, and a new one in Current Biology caught my eye this week. My own lab website has the URL chromatin.com so that says something. You can also read more about our research here. Recommended reads: chromatin and stem cells, more Asymmetric
Weekly recommended reads including asymmetric division & chromatin Read More »
What can a gecko possibly teach us about skin cancer? Read on. It’s fun when a week’s worth of science reading covers so much territory including COVID-19, geckos that get cancer, a research misconduct sleuth, an FDA letter, and more. Baltimore weighs in on COVID lab origin idea Caltech has a very interesting interview with
Recommended reads: Bik, FDA letter, gecko cancer model, David Baltimore on COVID origin Read More »